Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Prostate Cancer

  Free Subscription


Articles published in Urology

Retrieve available abstracts of 84 articles:
HTML format
Text format



Single Articles


    October 2018
  1. QUARRIER SO, Matloubieh JE, Wu G
    Robot-Assisted Placement of Pelvic Tissue Expander for Radiation after Prostatectomy and Cystectomy for Treatment of Prostate Cancer Biochemical Recurrence.
    Urology. 2018 Oct 29. pii: S0090-4295(18)31068.
    PubMed     Text format     Abstract available


  2. ALBALA D, Manak MS, Varsanik JS, Rashid HH, et al
    Clinical proof-of-concept of a novel platform utilizing biopsy-derived live single cells, phenotypic biomarkers, and machine learning toward a precision risk stratification test for Prostate Cancer Grade Groups 1 and 2 (Gleason 3+3 and 3+4).
    Urology. 2018 Oct 9. pii: S0090-4295(18)31073.
    PubMed     Text format     Abstract available


    September 2018
  3. GIANNARINI G, Girometti R, Crestani A, Rossanese M, et al
    A prospective accuracy study of Prostate Imaging Reporting and Data System version 2 on multiparametric magnetic resonance imaging in detecting clinically significant prostate cancer with whole-mount pathology.
    Urology. 2018 Sep 28. pii: S0090-4295(18)31054.
    PubMed     Text format     Abstract available


  4. TEELING F, Raison MN, Shabbir MM, Yap MT, et al
    Testosterone therapy for high-risk prostate cancer survivors: a systematic review and meta-analysis.
    Urology. 2018 Sep 20. pii: S0090-4295(18)30993.
    PubMed     Text format     Abstract available


  5. OBMANN VC, Pahwa S, Tabayayong W, Jiang Y, et al
    Diagnostic accuracy of a rapid biparametric MRI protocol for detection of histologically proven prostate cancer.
    Urology. 2018 Sep 7. pii: S0090-4295(18)30920.
    PubMed     Text format     Abstract available


    August 2018
  6. DIX DB, McDonald AM, Gordetsky JB, Nix JW, et al
    How Would MRI-Targeted Prostate Biopsy Alter Radiation Therapy Approaches in Treating Prostate Cancer?
    Urology. 2018 Aug 30. pii: S0090-4295(18)30911.
    PubMed     Text format     Abstract available


  7. SU R, Xu G, Xiang L, Ding S, et al
    A novel scoring system for prediction of prostate cancer based on shear wave elastography and clinical parameters.
    Urology. 2018 Aug 29. pii: S0090-4295(18)30910.
    PubMed     Text format     Abstract available


  8. HUNTLEY JH, Coley RY, Carter HB, Radhakrishnan A, et al
    Clinical evaluation of an individualized risk prediction tool for men on active surveillance for prostate cancer.
    Urology. 2018 Aug 29. pii: S0090-4295(18)30903.
    PubMed     Text format     Abstract available


  9. CAPOGROSSO P, Capitanio U, Vertosick EA, Ventimiglia E, et al
    Temporal trend in incidental prostate cancer detection at surgery for benign prostatic hyperplasia.
    Urology. 2018 Aug 20. pii: S0090-4295(18)30783.
    PubMed     Text format     Abstract available


  10. LEAPMAN MS, Wang R, Park HS, Yu JB, et al
    Association Between Prostate MRI and Observation for Low-Risk Prostate Cancer.
    Urology. 2018 Aug 11. pii: S0090-4295(18)30815.
    PubMed     Text format     Abstract available


    July 2018
  11. ZWAANS BMM, Bartolone SN, Chancellor MB, Nicolai H, et al
    Altered angiogenic growth factors in urine of prostate cancer survivors with radiation history and radiation cystitis.
    Urology. 2018 Jul 27. pii: S0090-4295(18)30779.
    PubMed     Text format     Abstract available


  12. MAHRAN A, Turk A, Buzzy C, Wang M, et al
    Younger Men with Prostate Cancer have Lower Risk of Upgrading while on Active Surveillance: A Meta-analysis and Systematic Review of the Literature.
    Urology. 2018 Jul 26. pii: S0090-4295(18)30773.
    PubMed     Text format     Abstract available


  13. KIM AH, Konety B, Chen Z, Schumacher F, et al
    COMPARATIVE EFFECTIVENESS OF LOCAL AND SYSTEMIC THERAPY FOR T4 PROSTATE CANCER.
    Urology. 2018 Jul 7. pii: S0090-4295(18)30630.
    PubMed     Text format     Abstract available


  14. MODI PK, Kaufman SR, Qi J, Lane BR, et al
    National Trends in Active Surveillance for Prostate Cancer: Validation of Medicare Claims-based Algorithms.
    Urology. 2018 Jul 7. pii: S0090-4295(18)30628.
    PubMed     Text format     Abstract available


    June 2018
  15. MENG Y, Vetter JM, Parker AA, Arett CT, et al
    Improved Detection of Clinically Significant Prostate Cancer with Software-Assisted Systematic Biopsy Using MR/US Fusion in Patients with Negative Prostate MRI.
    Urology. 2018 Jun 26. pii: S0090-4295(18)30588.
    PubMed     Text format     Abstract available


    May 2018
  16. MEDINA LG, Cacciamani GE, Hernandez A, Landsberger H, et al
    Robotic Management of Recto-Urethral Fistulas after Focal Treatment for Prostate Cancer.
    Urology. 2018 May 22. pii: S0090-4295(18)30469.
    PubMed     Text format     Abstract available


  17. KAYE DR, Qi J, Morgan TM, Linsell S, et al
    Association between Early Confirmatory Testing and the Adoption of Active Surveillance for Men with Favorable-Risk Prostate Cancer.
    Urology. 2018 May 21. pii: S0090-4295(18)30471.
    PubMed     Text format     Abstract available


  18. BUELENS S, Van Praet C, Poelaert F, Van Huele A, et al
    Prospective, Randomized Controlled Trial Exploring the Effect of TachoSil(R) on Lymphocele Formation after Extended Pelvic Lymph Node Dissection in Prostate Cancer.
    Urology. 2018 May 15. pii: S0090-4295(18)30463.
    PubMed     Text format     Abstract available


  19. ZHANG S, Li LH, Qiao HM, Yang X, et al
    Regulation of the Antioxidant-Response by MyoD Transcriptional Coactivator in Castration-Resistant Prostate Cancer Cells.
    Urology. 2018 May 3. pii: S0090-4295(18)30397.
    PubMed     Text format     Abstract available


  20. LI Q, Xiang F, Lin X, Grajo JR, et al
    The Role of Imaging in Prostate Cancer Care Pathway: Novel Approaches to Urologic Management Challenges Along Ten Imaging Touch Points.
    Urology. 2018 May 3. pii: S0090-4295(18)30395.
    PubMed     Text format     Abstract available


  21. MERRET C, Mannas M, Black PC, Zargar H, et al
    Magnet before the Needle: Commentary on MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis (PRECISION Trial).
    Urology. 2018 May 3. pii: S0090-4295(18)30393.
    PubMed     Text format    


    April 2018
  22. LUCKENBAUGH AN, Hollenbeck BK, Kaufman SR, Yan P, et al
    Impact of Accountable Care Organizations on Diagnostic Testing for Prostate Cancer.
    Urology. 2018 Apr 6. pii: S0090-4295(18)30300.
    PubMed     Text format     Abstract available


  23. VELASQUEZ MC, Chinea FM, Kwon D, Prakash NS, et al
    The Influence of Ethnic Heterogeneity on Prostate Cancer Mortality after Radical Prostatectomy in Hispanic/Latino Men: A Population-Based Analysis.
    Urology. 2018 Apr 6. pii: S0090-4295(18)30293.
    PubMed     Text format     Abstract available


    March 2018
  24. KESCH C, Black PC
    Filling a True Unmet Need: a New Therapy for Non-Metastatic Castrate Resistant Prostate Cancer. Commentary on: Apalutamide Treatment and Metastasis-Free Survival in Prostate Cancer.
    Urology. 2018 Mar 26. pii: S0090-4295(18)30260.
    PubMed     Text format    


  25. BJURLIN MA, Turkbey B, Rosenkrantz AB, Gaur S, et al
    Imaging the High-Risk Prostate Cancer Patient: Current and Future Approaches to Staging.
    Urology. 2018 Mar 12. pii: S0090-4295(17)31305.
    PubMed     Text format     Abstract available


    February 2018
  26. RADHAKRISHNAN A, Grande D, Mitra N, Pollack CE, et al
    Which Patients Report That Their Urologists Advised Them to Forgo Initial Treatment for Prostate Cancer?
    Urology. 2018 Feb 22. pii: S0090-4295(18)30160.
    PubMed     Text format     Abstract available


  27. WOJNO L, Minutella C, Moylan D, Bush A, et al
    Specimen Provenance Testing Identifies Contamination That Affects Molecular Prognostic Assay Results in Prostate Cancer Biopsy Specimens.
    Urology. 2018 Feb 21. pii: S0090-4295(18)30162.
    PubMed     Text format     Abstract available


    January 2018
  28. CANCIAN M, Renzulli JF 2nd
    Non Metastatic Castration Resistant Prostate Cancer: a Modern Perspective.
    Urology. 2018 Jan 18. pii: S0090-4295(18)30044.
    PubMed     Text format     Abstract available


  29. WALLIS CJD, Satkunasivam R, Herschorn S, Law C, et al
    Association between Primary Local Treatment and Non-Prostate Cancer Mortality in Men with Non-Metastatic Prostate Cancer.
    Urology. 2018 Jan 2. pii: S0090-4295(17)31330.
    PubMed     Text format     Abstract available


    December 2017
  30. TANG V, Campbell P, Pattison DA
    Lymphangitic Carcinomatosis From Prostate Cancer Identified with Gallium-68 Prostate-Specific Membrane Antigen Positron Emission Tomography Imaging.
    Urology. 2017 Dec 29. pii: S0090-4295(17)31327.
    PubMed     Text format     Abstract available


  31. WERNEBURG GT, Kongnyuy M, Halpern DM, Salcedo JM, et al
    Effects of Focal Versus Total Cryotherapy and Minimum Tumor Temperature on Patient-Reported Quality of Life as Compared to Active Surveillance in Prostate Cancer Patients.
    Urology. 2017 Dec 22. pii: S0090-4295(17)31302.
    PubMed     Text format     Abstract available


  32. KAHOKEHR AA, Peterson AC
    Unmasking of Urinary-Pubic Symphysis Fistula (UPF) after Implantation of Artificial Urinary Sphincter in Prostate Cancer Survivors - User Beware. Url-D-17-02187.
    Urology. 2017 Dec 22. pii: S0090-4295(17)31301.
    PubMed     Text format     Abstract available


  33. ULLMAN D, Dorn D, Rais-Bahrami S, Gordetsky J, et al
    Clinical Utility and Biologic implications of Phosphatase and Tensin Homolog (PTEN) and ETS-related Gene (ERG) in Prostate Cancer.
    Urology. 2017 Dec 7. pii: S0090-4295(17)31219.
    PubMed     Text format     Abstract available


    November 2017
  34. WALLIS CJD, Satkunasivam R, Saskin R, Bansal S, et al
    Population-Based Analysis of Treatment Toxicity among Men with Castration-Resistant Prostate Cancer: a Phase IV Study.
    Urology. 2017 Nov 27. pii: S0090-4295(17)31221.
    PubMed     Text format     Abstract available



  35. Erratum to "Postoperative Adjuvant and Salvage Radiotherapy for Prostate Cancer: Impact on Freedom From Biochemical Relapse and Survival".
    Urology. 2017 Nov 20. pii: S0090-4295(17)31088.
    PubMed     Text format    


  36. BJURLIN MA, Rosenkrantz AB, Sarkar S, Lepor H, et al
    Prediction of Prostate Cancer Risk among Men Undergoing Combined MRI-Targeted and Systematic Biopsy Using Novel Pre-Biopsy Nomograms That Incorporate MRI Findings.
    Urology. 2017 Nov 16. pii: S0090-4295(17)31185.
    PubMed     Text format     Abstract available


  37. BARQAWI A, Huebner E, Krughoff K, O'Donnell CI, et al
    Prospective Outcome Analysis of the Safety and Efficacy of Partial and Complete Cryoablation in Organ-Confined Prostate Cancer.
    Urology. 2017 Nov 7. pii: S0090-4295(17)31163.
    PubMed     Text format     Abstract available


    October 2017
  38. ZHONG W, Smith B, Haghighi K, Mancuso P, et al
    Systematic Review of Decision Aids for the Management of Men with Localized Prostate Cancer.
    Urology. 2017 Oct 31. pii: S0090-4295(17)31154.
    PubMed     Text format     Abstract available


  39. SHARMA V, Yousefi K, Haddad Z, Buerki C, et al
    Gene Expression Correlates of Site-Specific Metastasis among Men with Lymph Node Positive Prostate Cancer Treated with Radical Prostatectomy: a Case Series.
    Urology. 2017 Oct 24. pii: S0090-4295(17)31099.
    PubMed     Text format     Abstract available


  40. KENIGSBERG AP, Llukani E, Deng FM, Melamed J, et al
    The Use of MRI to Predict Oncological Control among Candidates for Focal Ablation of Prostate Cancer.
    Urology. 2017 Oct 20. pii: S0090-4295(17)31097.
    PubMed     Text format     Abstract available


  41. NGUYEN A, O'Leary MP
    Re: Deebel et al.: Prostate Cancer in Transgender Women: Incidence, Etiopathogenesis, and Management Challenges (Urology 2017, http://dx.doi.org/doi:10.1016/j.urology.2017.08.032).
    Urology. 2017 Oct 16. pii: S0090-4295(17)31076.
    PubMed     Text format    


    September 2017
  42. QURESHI ZP, Sartor O, Bennett CL
    Calling Order to Chaos: Treatment Decision Making in Metastatic Castrate-resistant Prostate Cancer.
    Urology. 2017 Sep 20. pii: S0090-4295(17)30750.
    PubMed     Text format    


  43. SHORE N, Heidenreich A, Saad F
    Author Response on the Manuscript Titled "Calling Order to Chaos: Treatment Decision Making in Metastatic Castrate-resistant Prostate Cancer" (#URL-D-17-01121).
    Urology. 2017 Sep 20. pii: S0090-4295(17)30751.
    PubMed     Text format    


  44. GOLOMBOS DM, Ayangbesan A, O'Malley P, Lewicki P, et al
    The Role of Gut Microbiome in the Pathogenesis of Prostate Cancer: a Prospective, Pilot Study.
    Urology. 2017 Sep 6. pii: S0090-4295(17)30957.
    PubMed     Text format     Abstract available


  45. WIENER S, Haddock P, Cusano J, Staff I, et al
    Incidence of Clinically Significant Prostate Cancer after a Diagnosis of Atypical Small Acinar Proliferation (ASAP), High Grade Prostatic Intraepithelial Neoplasia (HGPIN), or Benign Tissue.
    Urology. 2017 Sep 6. pii: S0090-4295(17)30958.
    PubMed     Text format     Abstract available


  46. DEEBEL NA, Morin JP, Autorino R, Vince R, et al
    Prostate Cancer in Transgender Women: Incidence, Etiopathogenesis, and Management Challenges.
    Urology. 2017 Sep 4. pii: S0090-4295(17)30906.
    PubMed     Text format     Abstract available


    August 2017
  47. BOESEN L, Norgaard N, Logager V, Balslev I, et al
    Where Do TRUS- and MRI Guided Biopsies Miss Significant Prostate Cancer?
    Urology. 2017 Aug 30. pii: S0090-4295(17)30899.
    PubMed     Text format     Abstract available


  48. FRIEDL A, Stangl K, Bauer W, Kivaranovic D, et al
    Prostate-Specific Antigen Parameters and Prostate Health Index Enhance Prostate Cancer Prediction with the in-Bore 3-T MRI-Guided Transrectal Targeted Prostate Biopsy after Negative 12-Core Biopsy.
    Urology. 2017 Aug 24. pii: S0090-4295(17)30880.
    PubMed     Text format     Abstract available


  49. OROM H, Biddle C, Underwood W 3rd, Homish GG, et al
    Racial/Ethnic and Socioeconomic Disparities in Prostate Cancer Survivors' Prostate-Specific Quality of Life.
    Urology. 2017 Aug 22. pii: S0090-4295(17)30866.
    PubMed     Text format     Abstract available


  50. BHINDI B, Carlson RE, Mason RJ, Schulte PJ, et al
    Long-Term Follow Up of a Matched Cohort Study Evaluating the Role of Adjuvant Radiotherapy for Organ-Confined Prostate Cancer with a Positive Surgical Margin.
    Urology. 2017 Aug 17. pii: S0090-4295(17)30853.
    PubMed     Text format     Abstract available


  51. AAS K, Axcrona K, Kvale R, Moller B, et al
    10-Year Mortality in Men with Non-Metastatic Prostate Cancer in Norway.
    Urology. 2017 Aug 17. pii: S0090-4295(17)30860.
    PubMed     Text format     Abstract available


  52. SHORE N, Heidenreich A, Saad F
    Predicting Response and Recognizing Resistance: Improving Outcomes in Patients with Castration-Resistant Prostate Cancer.
    Urology. 2017 Aug 7. pii: S0090-4295(17)30745.
    PubMed     Text format     Abstract available


  53. STRUSS WJ, Black PC
    Commentary on: Abiraterone Plus Prednisolone in Metastatic, Castration-Sensitive Prostate Cancer.
    Urology. 2017 Aug 7. pii: S0090-4295(17)30779.
    PubMed     Text format    


    July 2017
  54. ZACHO HD, Gade M, Mortensen JC, Bertelsen H, et al
    Bone Scan Index is an Independent Predictor for Time to Castration-Resistant Prostate Cancer in Newly Diagnosed Prostate Cancer: a Prospective Study.
    Urology. 2017 Jul 28. pii: S0090-4295(17)30759.
    PubMed     Text format     Abstract available


  55. ZACHO HD, Petersen LJ
    Reply by the authors to the Editorial on: Zacho HD, Gade M, Mortensen JC, Bertelsen H, Boldsen SK, Petersen LJ. Bone scan index is an independent predictor for time to castration resistant prostate cancer in newly diagnosed prostate cancer: A prospect
    Urology. 2017 Jul 26. pii: S0090-4295(17)30760.
    PubMed     Text format    


  56. HORIGUCHI A, Shinchi M, Nakamura A, Wada T, et al
    Pilot Study of Prostate Cancer Angiogenesis Imaging Using a Photoacoustic Imaging System.
    Urology. 2017 Jul 19. pii: S0090-4295(17)30733.
    PubMed     Text format     Abstract available


    June 2017
  57. SKOLARUS TA, Ragnoni JA, Garlinghouse C, Schafenacker A, et al
    Multilingual Self-Management Resources for Prostate Cancer Survivors and Their Partners: Results of a Long-Term Academic-State Health Department Partnership to Promote Survivorship Care.
    Urology. 2017 Jun 23. pii: S0090-4295(17)30637.
    PubMed     Text format     Abstract available


  58. GORIN MA, Pienta KJ, Pomper MG, Rowe SP, et al
    Prostate Cancer Local Recurrence Detected with Both 18F-Fluciclovine and PSMA-Targeted 18F-DCFPyL PET/CT.
    Urology. 2017 Jun 19. pii: S0090-4295(17)30635.
    PubMed     Text format     Abstract available


  59. MANNAS M, Chedgy E, Black PC
    You Pays Your Money, You Takes Your Choice: Functional Outcomes Following Curative Treatment for Clinically Localized Prostate Cancer.
    Urology. 2017 Jun 15. pii: S0090-4295(17)30625.
    PubMed     Text format    


  60. GRIVAS N, van der Roest R, Tillier C, Schouten D, et al
    Patterns of Benign Prostate Hyperplasia Based on Magnetic Resonance Imaging are Correlated with Lower Urinary Tract Symptoms and Continence in Men Undergoing a Robot-Assisted Radical Prostatectomy for Prostate Cancer.
    Urology. 2017 Jun 7. pii: S0090-4295(17)30604.
    PubMed     Text format     Abstract available


    May 2017
  61. HEGDE JV, Veruttipong D, Said JW, Reiter RE, et al
    Prostate Cancer Antigen 3 (PCA3) Score Does Not Predict for Adverse Pathologic Features at Radical Prostatectomy or for Progression-Free Survival in Clinically-Localized, Intermediate- and High-Risk Prostate Cancer.
    Urology. 2017 May 25. pii: S0090-4295(17)30565.
    PubMed     Text format     Abstract available


    April 2017
  62. DAVIS K, Bellini P, Hagerman C, Zinar R, et al
    Physicians' Perceptions of Factors Influencing the Treatment Decision-Making Process for Men with Low-Risk Prostate Cancer.
    Urology. 2017 Apr 25. pii: S0090-4295(17)30391.
    PubMed     Text format     Abstract available


  63. CANTIELLO F, Gangemi V, Cascini GL, Calabria F, et al
    Diagnostic Accuracy of 64Cu-PSMA PET/CT for Primary Lymph Node Staging of Intermediate to High Risk Prostate Cancer: Our Preliminary Experience.
    Urology. 2017 Apr 21. pii: S0090-4295(17)30385.
    PubMed     Text format     Abstract available


  64. XIA L, Zeh R, Mizelle J, Newton A, et al
    Near-Infrared Intraoperative Molecular Imaging Can Identify Metastatic Lymph Nodes in Prostate Cancer.
    Urology. 2017 Apr 21. pii: S0090-4295(17)30386.
    PubMed     Text format     Abstract available


  65. POELAERT F, Verbaeys C, Rappe B, Kimpe B, et al
    Cytoreductive Prostatectomy for Metastatic Prostate Cancer: First Lessons Learned From the Multicentric Prospective LoMP Trial.
    Urology. 2017 Apr 20. pii: S0090-4295(17)30372.
    PubMed     Text format     Abstract available


  66. JUE JS, Barboza MP, Prakash NS, Venkatramani V, et al
    Re-Examining PSA Density: Defining the Optimal PSA Range and Patients for Using PSA Density to Predict Prostate Cancer Using Extended Template Biopsy.
    Urology. 2017 Apr 18. pii: S0090-4295(17)30368.
    PubMed     Text format     Abstract available


  67. GUERRIOS-RIVERA L, Howard L, Frank J, De Hoedt A, et al
    Is BMI the Best Adiposity Measure for Prostate Cancer Risk? Results From a VA Biopsy Cohort.
    Urology. 2017 Apr 10. pii: S0090-4295(17)30347.
    PubMed     Text format     Abstract available


    March 2017
  68. JOHNSTON J, Struss WJ, Black PC
    Padeliporfin Vascular-Targeted Photodynamic Therapy Versus Active Surveillance in Men with Low-Risk Prostate Cancer (Clin1001 PCM301): an Open-Label, Phase 3, Randomised Control Trial.
    Urology. 2017 Mar 22. pii: S0090-4295(17)30274.
    PubMed     Text format    


  69. STRUSS WJ, Black PC
    Radiation with or Without Antiandrogen Therapy in Recurrent Prostate Cancer.
    Urology. 2017 Mar 22. pii: S0090-4295(17)30275.
    PubMed     Text format    


  70. PAKZAD R, Safiri S
    Unexplained Bone Pain is an Independent Risk Factor for Bone Metastases in Newly Diagnosed Prostate Cancer: a Prospective Study; Methodological Issues.
    Urology. 2017 Mar 21. pii: S0090-4295(17)30272.
    PubMed     Text format    


  71. ZACHO HD, Morch CD, Barsi T, Mortensen JC, et al
    Reply to Letter-to-the-Editor: Unexplained Bone Pain is an Independent Risk Factor for Bone Metastases in Newly Diagnosed Prostate Cancer: a Prospective Study, Published in Urology. 2017 Jan;99:148-154.
    Urology. 2017 Mar 20. pii: S0090-4295(17)30269.
    PubMed     Text format    


  72. JOSHI A, Nicholson C, Rhee H, Gustafson S, et al
    Incidental Malignancies identified during staging for Prostate Cancer with 68Ga -PSMA HBED-CC PET imaging.
    Urology. 2017 Mar 20. pii: S0090-4295(17)30271.
    PubMed     Text format     Abstract available


  73. LU AJ, Syed JS, Nguyen KA, Nawaf CB, et al
    Negative Multi-Parametric MRI of the Prostate Predicts Absence of Clinically Significant Prostate Cancer on 12-Core Template Prostate Biopsy.
    Urology. 2017 Mar 16. pii: S0090-4295(17)30247.
    PubMed     Text format     Abstract available


  74. PAKZAD R, Safiri S
    Cognitive Effects of Androgen Deprivation Therapy in Men with Advanced Prostate Cancer: Methodological Issues.
    Urology. 2017 Mar 15. pii: S0090-4295(17)30244.
    PubMed     Text format    



  75. Erratum to "Predictors of Time to Metastasis in Castration-resistant Prostate Cancer".
    Urology. 2017 Mar 14. pii: S0090-4295(17)30113.
    PubMed     Text format    


    February 2017
  76. JOHNSON SC, Packiam VT, Golan S, Cohen AJ, et al
    The Effect of Obesity on Perioperative Outcomes for Open and Minimally Invasive Prostatectomy.
    Urology. 2017;100:111-116.
    PubMed     Text format     Abstract available


  77. BORHAN W, Epstein JI
    Significance of Gleason Score 7 With Tertiary Pattern 5 at Radical Prostatectomy.
    Urology. 2017;100:175-179.
    PubMed     Text format     Abstract available


  78. KOMINSKY HD, Bashline M, Eun D, Pontari MA, et al
    Use of Age and Medical Comorbidity to Assess Long-term Other-cause Mortality Risk in a Cohort of Men Undergoing Prostate Biopsy at an Academic Medical Center.
    Urology. 2017;100:169-174.
    PubMed     Text format     Abstract available


    January 2017
  79. ZARGAR-SHOSHTARI K, Lawrentschuk N, Zargar H
    Robotic Prostatectomy Delivers on the Promise of Minimally Invasive Surgery: Commentary on: Robot-assisted Laparoscopic Prostatectomy Versus Open Radical Retropubic Prostatectomy: Early Outcomes from a Randomised Controlled Phase 3 Study.
    Urology. 2017;99:3-4.
    PubMed     Text format    


    August 2016
  80. LIU JS, Hofer MD, Sheth KR, Cordon BH, et al
    Improving Outcomes of Bulbomembranous Urethroplasty for Radiation-Induced Urethral Strictures in Post-Urolume Era.
    Urology. 2016 Aug 2. pii: S0090-4295(16)30459.
    PubMed     Text format     Abstract available


    July 2016
  81. HOFER MD, Morey AF, Sheth K, Tausch TJ, et al
    Low Serum Testosterone Level Predisposes to Artificial Urinary Sphincter Cuff Erosion.
    Urology. 2016 Jul 20. pii: S0090-4295(16)30422.
    PubMed     Text format     Abstract available


    May 2016
  82. QUINTANA L, Ward A, Gerrin SJ, Genega EM, et al
    Gleason Misclassification Rate Is Independent of Number of Biopsy Cores in Systematic Biopsy.
    Urology. 2016;91:143-9.
    PubMed     Text format     Abstract available


  83. KARATZAS AD, Zachos I, Mitrakas L, Dimitropoulos K, et al
    Generalized Lymphadenopathy of Prostate Adenocarcinoma Origin. A Case Series.
    Urology. 2016;91:e3-4.
    PubMed     Text format     Abstract available


  84. DASON S, Allard CB, Wright I, Shayegan B, et al
    Transurethral Resection of the Prostate Biopsy of Suspected Anterior Prostate Cancers Identified by Multiparametric Magnetic Resonance Imaging: A Pilot Study of a Novel Technique.
    Urology. 2016;91:129-35.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: